135 related articles for article (PubMed ID: 9219441)
1. Metabolism of proteins and glycoproteins in tumour bearing mice treated with Aeromonas L-asparaginase.
Benny PJ; Muraleedhara KG; Sreejith K; Jayashree G
Indian J Biochem Biophys; 1996 Dec; 33(6):527-30. PubMed ID: 9219441
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolism in tumour bearing mice treated withAeromonas L-asparaginase.
Benny PJ; Kurup GM; Sreejith K
Indian J Clin Biochem; 1997 Jul; 12(2):108-13. PubMed ID: 23100875
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
4. L-asparaginase activity in Aeromonas sp. isolated from freshwater mussel.
Pattnaik S; Kabi R; Janaki Ram K; Bhanot KK
Indian J Exp Biol; 2000 Nov; 38(11):1143-6. PubMed ID: 11395960
[TBL] [Abstract][Full Text] [Related]
5. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
Holcenberg JS
Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
[TBL] [Abstract][Full Text] [Related]
6. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
Nath CE; Dallapozza L; Eslick AE; Misra A; Carr D; Earl JW
Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071
[TBL] [Abstract][Full Text] [Related]
7. [Effect of the Japanese cucumaria on phospholipid metabolism in the liver of mice with solid Ehrlich carcinoma].
Bulysheva VS; Maslova MG; Boĭkova EA; Partolin NN
Eksp Onkol; 1986; 8(4):70-2. PubMed ID: 3757890
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antineoplastic activity of extracellular asparaginase produced by isolated Bacillus circulans.
Prakasham RS; Hymavathi M; Subba Rao Ch; Arepalli SK; Venkateswara Rao J; Kennady PK; Nasaruddin K; Vijayakumar JB; Sarma PN
Appl Biochem Biotechnol; 2010 Jan; 160(1):72-80. PubMed ID: 19543838
[TBL] [Abstract][Full Text] [Related]
9. Nitrogen utilization in mice bearing Ehrlich ascites tumor treated with Acinetobacter glutaminase-asparaginase.
Kien CL; Holcenberg JS
Cancer Res; 1981 Jun; 41(6):2051-5. PubMed ID: 7237413
[TBL] [Abstract][Full Text] [Related]
10. [Absorption in vitro, by malignant cells, of serum proteins of rabbits and agoutis (l-asparaginase) conjugated with fluorescent substances].
Wanick LR
Rev Inst Antibiot (Recife); 1971 Jun; 11(1):39-42. PubMed ID: 5161610
[No Abstract] [Full Text] [Related]
11. [Binding of the antileukemia drug Escherichia coli L-asparaginase to the plasma membrane of normal human mononuclear cells].
Mercado-Vianco L; Arenas-Díaz G
Sangre (Barc); 1999 Jun; 44(3):204-9. PubMed ID: 10481582
[TBL] [Abstract][Full Text] [Related]
12. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, physicochemical and immunological properties of oxidized inulin-L-asparaginase bioconjugate.
Tabandeh MR; Aminlari M
J Biotechnol; 2009 May; 141(3-4):189-95. PubMed ID: 19433225
[TBL] [Abstract][Full Text] [Related]
14. Uptake of drug-resistant tumour cell fractions by drug-sensitive tumour cells.
Ujhăzy V; Kuzela S; Krempasky V; Bohunickă E
Neoplasma; 1971; 18(6):627-30. PubMed ID: 5172114
[No Abstract] [Full Text] [Related]
15. [Experimental results in radiochemotherapy using L-asparaginase].
Ringleb D; Billger J; Busch E; Haeger V; Jung A; Kratz L
Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:192-3. PubMed ID: 4341092
[No Abstract] [Full Text] [Related]
16. [Distribution of exogenous and endogenous L-asparaginase in mice].
Wierer U; Pütter J
Arzneimittelforschung; 1972 Apr; 22(4):791-5. PubMed ID: 5068262
[No Abstract] [Full Text] [Related]
17. A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
Ylikangas P; Mononen I
Anal Biochem; 2000 Apr; 280(1):42-5. PubMed ID: 10805519
[TBL] [Abstract][Full Text] [Related]
18. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
19. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
Ronghe M; Burke GA; Lowis SP; Estlin EJ
Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
[TBL] [Abstract][Full Text] [Related]
20. Serum LDH and ALP isozyme activities in mice bearing solid Ehrlich carcinoma and/or treated with the maximum tolerated dose (MTD) of aloin.
Fahim FA; Esmat AY; Mady EA; Amin MA
Dis Markers; 1997 Nov; 13(3):183-93. PubMed ID: 9405931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
